Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Establishment Labs Holdings Inc. - Common Shares (NQ: ESTA )

29.96 +0.18 (+0.60%)
Streaming Delayed Price Updated: 12:22 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 129,416
Open 30.40
Bid (Size) 29.82 (3)
Ask (Size) 29.99 (1)
Prev. Close 29.78
Today's Range 29.16 - 30.50
52wk Range 26.55 - 60.12
Shares Outstanding 23,739,353
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Establishment Labs to Announce First Quarter 2025 Financial Results on May 7
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Provides Preliminary First Quarter Results and Announces an Investor Day on June 12
From Establishment Labs Holdings Inc.
Via Business Wire

Performance

YTD
-33.83%
-33.83%
1 Month
-27.32%
-27.32%
3 Month
-17.31%
-17.31%
6 Month
-33.36%
-33.36%
1 Year
-39.71%
-39.71%

More News

Read More
Establishment Labs Notes Presentation of 5-Year Results from Motiva U.S. IDE Study at The Aesthetic MEET 2025
From Establishment Labs Holdings Inc.
Via Business Wire
Earnings Scheduled For February 26, 2025
Via Benzinga
Exploring Establishment Labs Hldgs's Earnings Expectations
Via Benzinga
Critical Insights From Establishment Labs Hldgs Analyst Ratings: What You Need To Know
Via Benzinga
Deep Dive Into Establishment Labs Hldgs Stock: Analyst Perspectives (5 Ratings)
Via Benzinga
Establishment Labs Reports Fourth Quarter and Full Year 2024 Financial Results and Reaffirms 2025 Guidance
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Present at TD Cowen's 45th Annual Health Care Conference
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Present at Citi’s 2025 Unplugged Medtech and Life Sciences Access Day
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Launches Preservé™
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Announce Fourth Quarter 2024 Financial Results on February 26
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces CEO Transition
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Participation in Upcoming Investment Conferences
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces $50 Million Registered Direct Offering
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Reports Third Quarter 2024 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Three-Year Mia Femtech Clinical Results at 9th World Symposium on Ergonomic Implants
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Announce Third Quarter 2024 Financial Results on November 7
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Publishes 2024 Post Market Surveillance Report
From Establishment Labs Holdings Inc.
Via Business Wire
First U.S. Women Successfully Receive Breast Augmentation with New FDA Approved Motiva Implants
From Establishment Labs Holdings Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Establishment Labs Receives U.S. FDA Approval for Motiva Implants
From Establishment Labs Holdings Inc.
Via Business Wire
ESTA Stock Earnings: Establishment Labs Hldgs Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.